DE69939951D1 - Polypeptide-k erhalten vom momordica charantia and eine methode für sein extraktion - Google Patents

Polypeptide-k erhalten vom momordica charantia and eine methode für sein extraktion

Info

Publication number
DE69939951D1
DE69939951D1 DE69939951T DE69939951T DE69939951D1 DE 69939951 D1 DE69939951 D1 DE 69939951D1 DE 69939951 T DE69939951 T DE 69939951T DE 69939951 T DE69939951 T DE 69939951T DE 69939951 D1 DE69939951 D1 DE 69939951D1
Authority
DE
Germany
Prior art keywords
polypeptide
extraction
receive
momordica charantia
momordica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939951T
Other languages
English (en)
Inventor
Pushpa Khanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN560DE1999 external-priority patent/IN188673B/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69939951D1 publication Critical patent/DE69939951D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69939951T 1999-04-13 1999-09-28 Polypeptide-k erhalten vom momordica charantia and eine methode für sein extraktion Expired - Lifetime DE69939951D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN561DE1999 1999-04-13
IN560DE1999 IN188673B (de) 1999-04-13 1999-04-13
PCT/IN1999/000052 WO2000061619A1 (en) 1999-04-13 1999-09-28 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof

Publications (1)

Publication Number Publication Date
DE69939951D1 true DE69939951D1 (de) 2009-01-02

Family

ID=26324634

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939951T Expired - Lifetime DE69939951D1 (de) 1999-04-13 1999-09-28 Polypeptide-k erhalten vom momordica charantia and eine methode für sein extraktion

Country Status (9)

Country Link
US (1) US6831162B2 (de)
EP (1) EP1171455B1 (de)
JP (1) JP3877530B2 (de)
CN (1) CN100413884C (de)
AT (1) ATE414714T1 (de)
AU (1) AU774836B2 (de)
CA (1) CA2369908C (de)
DE (1) DE69939951D1 (de)
WO (1) WO2000061619A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669348B2 (en) 2007-03-30 2014-03-11 Aparna Dixit Anti diabetic protein
CN100596273C (zh) * 2007-05-10 2010-03-31 东方九星（北京）新技术有限公司 一套纯食品组合修复胰腺功能治愈ⅱ型糖尿病及食疗制法
US8071844B1 (en) 2007-09-13 2011-12-06 Nutritional Health Institute Laboratories, Llc Cultivated momordica species and extract thereof
WO2009098702A2 (en) * 2008-02-06 2009-08-13 Sadashiv Damle Ramchandra A hypoglycemic herbal extract composition for reducing blood sugar levels in mammals
CN102002095A (zh) * 2010-05-20 2011-04-06 中国药科大学 微波促进固相合成苦瓜降血糖mc-jj0108多肽类似物及其应用
ES2621355T3 (es) 2011-01-28 2017-07-03 Piramal Enterprises Limited Procedimiento para la preparación de un extracto de Momordica Charantia
CN104605136A (zh) * 2015-02-02 2015-05-13 王�锋 一种苦瓜多肽的制备方法
CN110679943A (zh) * 2019-10-25 2020-01-14 李玉保 具有减肥降脂效果的苦瓜多肽复合营养素及制备方法
CN111454342A (zh) * 2020-04-24 2020-07-28 广西壮族自治区农业科学院 一种苦瓜籽中降糖多肽k的提取方法
CN114028534B (zh) * 2021-12-10 2024-02-23 北海开元生物科技有限公司 一种治疗糖尿病的低分子量苦瓜多肽含片的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE403672T1 (de) * 1997-04-01 2008-08-15 Theracos Inc Oral aktive fraktion der momordica charantia, ihre aktiven peptide und ihre verwendung bei der behandlung des diabetes

Also Published As

Publication number Publication date
AU1889400A (en) 2000-11-14
JP3877530B2 (ja) 2007-02-07
JP2002543047A (ja) 2002-12-17
EP1171455B1 (de) 2008-11-19
US20020151687A1 (en) 2002-10-17
US6831162B2 (en) 2004-12-14
CA2369908A1 (en) 2000-10-19
CN1315964A (zh) 2001-10-03
WO2000061619A1 (en) 2000-10-19
CN100413884C (zh) 2008-08-27
EP1171455A1 (de) 2002-01-16
ATE414714T1 (de) 2008-12-15
CA2369908C (en) 2013-03-12
AU774836B2 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
Gerlach et al. Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa
EP2769715A3 (de) Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien
BR0207700A (pt) Método para tratar a diabete melito em um paciente em necessidade de tal tratamento, e, usos de um derivado de polipeptìdeo de insulina, e de um conjugado de polipeptìdeo de insulina-oligÈmero
BR0113198A (pt) Processo de obtenção de extratos à base de compostos polifenólicos contidos no cacau, extratos à base de compostos polifenólicos, utilização dos mesmos, complementos nutricionais e composições cosméticas
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
ATE414527T1 (de) Zubereitungen zur reizhemmenden rosacea- behandlung
LT2004060A (en) A composition for treating neurocerebrovascular disorders
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
BRPI9715334B8 (pt) agentes estrogênicos e composição farmacêutica compreendendo os mesmos.
NO20054769L (no) Substituerte fenylalkansyrer
WO2001087925A3 (en) Methods for refolding proteins containing free cysteine residues
DE69939951D1 (de) Polypeptide-k erhalten vom momordica charantia and eine methode für sein extraktion
ATE249516T1 (de) Nukleinsäure-isolierung
DK1299130T3 (da) Fremgangsmåde til behandling og forebyggelse af smitsomme sygdomme
ATE313802T1 (de) Bestimmung von adrenomedullin-bindenden proteinen
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
WO2006047470A3 (en) Compositions containing malva sylvestris extract and use thereof on skin or mucosal tissues
IL152406A0 (en) Anti-freeze proteins, their production and use
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
DE59900222D1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
ES2086274T3 (es) Preparaciones de especies de crataegus, composiciones farmaceuticas y su uso para prevenir la muerte subita debida a ataque cardiaco y las lesiones cardiovasculares provocadas por reperfusion.
ATE215376T1 (de) Salbe zur behandlung von verbrennungen und anderen hautkrankheiten
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
DE69615685D1 (de) Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition